Skip to main content
. 2015 Dec 11;7(5):5273–5288. doi: 10.18632/oncotarget.6567

Table 2. Genome rearrangements resulting in fusion transcripts identified in three cell lines.

Sample Gene fusion Rearrangement type
IOR/OS15 PMP22-ELOVL5 Translocation
IOR/OS15 GCC2-CCDC73 Translocation
IOR/OS15 RAI1-CLIC5 Translocation
IOR/OS15 TP53-PPRAD Translocation
IOR/OS15 MRPL39-MAML3 Translocation and deletion
IOR/OS15 PLXNA2-RUNX1 Translocation
IOR/OS15 SCO1-CLIC5 Translocation
IOR/OS15 EIF2S1-RBM25 Deletion
IOR/OS15 BAZ1A-NUMB Deletion
IOR/OS15 CDC5L-BTBD9 Inversion
IOR/OS15 MRPL39-NRIP1 Inversion
MG-63 DNER-ELL2 Translocation
MG-63 CLIP4-EPHB4 Translocation
MG-63 TP53-VAV1* Translocation
MG-63 TP53-EMR1* Translocation
MG-63 MROH1-PARP10 Inversion
MG-63 BNC2-MTAP Inversion
ZK-58 CREBBP-TFAP4 Deletion
ZK-58 GDPD5-MAP6 Deletion
*

One genomic translocation (TP53-VAV1) causing two different fusion transcripts involving the gene at the breakpoint (VAV1) and the gene next to it (EMR1).